Ledger.Open graph →
SEC Form D · Amendment · filed March 23, 2017

OncoResponse Inc

Offering
$34.0M
Sold
$29.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Russ Hawkinson · Seattle, WAExecSteve Gillis · Seattle, WADirectorClifford J. Stocks · Seattle, WAExec · DirectorWende Hutton · Seattle, WADirectorJames Winokur · Stoneham, MADirectorJose Larin · Yardley, PADirectorChristopher Day · Grand Cayman, Cayman IslandsExecRichard H. Coles · Grand Cayman, Cayman IslandsExec · DirectorRoberto De Ponti · Seattle, WADirectorAndrew Perlman · New York, NYDirectorAlan Ginsberg · Seattle, WADirectorMichael P. Bourque · Stoneham, MADirectorBrent K. Rentmeester · Stoneham, MAExec · DirectorMichael G. Clarke · Boston, MAExecGary A. Jacobs · Woburn, MADirectorRoberto De Ponti · Seattle, WADirectorAndrew Perlman · Seattle, WADirectorAlan Ginsberg · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗